33 completed, 4 terminated, 4 unknown, 1 recruiting. 43 Phase 3, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 43 | Completed 33, Terminated 4, Unknown 4, Recruiting 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 5, Recruiting 1, Unknown 1 |
Follow Diet: new trials by email Literature Review of Diet trials Research Report on Diet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction Low calorie meal replacement plan, Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy, Transthoracic echocardiography - Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic | Phase 2 / Phase 3 | Completed | University of Leicester | 66 | 2023-12-05 | 2026-07-22 |
| Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects Lifestyle Intervention, Dasatinib 100 MG, Quercetin 1000mg - Obesity, Healthy Lifestyle | Phase 2 / Phase 3 | Recruiting | Cedars-Sinai Medical Center | 160 | 2023-10-17 | 2026-03-18 |
| Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira IDegLira, insulin degludec, Metformin - Type 2 Diabetes Mellitus | Phase 3 | Completed | Population Health Research Institute | 159 | 2019-04-23 | 2023-10-25 |
| Survival Benefits of Statins in Breast Cancer Patients statins, Dietary intervention group (control group) - Breast Cancer Female | Phase 3 | Unknown | Peking Union Medical College Hospital | 314 | 2019-03-28 | 2019-08-14 |
| Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) Diet - Leukemia, Myelodysplastic Syndromes | Phase 3 | Terminated | University of Florida | 217 | 2017-08-18 | 2025-04-07 |
| Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi iGlarLixi, Insulin Glargine, Metformin - Type 2 Diabetes Mellitus | Phase 3 | Completed | Population Health Research Institute | 161 | 2017-06-27 | 2020-11-13 |
| Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita) insulin glargine, sitagliptin/metformin, lifestyle therapy - Type 2 Diabetes Mellitus | Phase 3 | Completed | Population Health Research Institute | 102 | 2016-07-09 | 2022-03-25 |
| Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin Alirocumab, Placebo, Atorvastatin - Hypercholesterolemia | Phase 3 | Completed | Sanofi | 163 | 2015-11-30 | 2019-01-23 |
| Weight Loss and Appetite Reduction After Percutaneous Electrical Stimulation Dermatome T6 PENS T6, TENS T11/T12, Hypocaloric 1200 Kcal/day diet - Weight Loss | Phase 3 | Completed | Hospital General Universitario Elche | 200 | 2015-07-01 | 2016-06-23 |
| PENS T6 With Ambulatory Self-applied Patch vs Conventional Procedure Self-applied patch, Conventional procedure, 1200 Kcal/day diet - Weight Loss | Phase 3 | Completed | Abdel Kadar Clinic | 90 | 2015-07-01 | 2015-10-01 |
| Effects of Self-conditioning Techniques in Promoting Weight Loss in Patients With Obesity. A Randomized Controlled Trial self-conditioning techniques, standard care (diet, exercise and behavioral therapy) - Obesity | Phase 3 | Completed | University of Turin, Italy | 120 | 2015-02-01 | 2018-01-24 |
| Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease Diet and water adjustment - Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 2 / Phase 3 | Completed | Tufts Medical Center | 34 | 2014-05-01 | 2017-03-30 |
| Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention Diet, Physical activity, Minimal diet intervention - Breast Neoplasms, Recurrence | Phase 3 | Unknown | Institut Català d'Oncologia | 2000 | 2014-01-01 | 2014-01-14 |
| Preoperative Diet Before Sleeve Gastrectomy Regular diet, High protein formula, Immunonutrition - Pain | Phase 3 | Completed | Hospital General Universitario Elche | 60 | 2014-01-01 | 2015-03-27 |
| Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II) Alirocumab, Placebo (for Alirocumab), Non-statin LMT - Hypercholesterolemia | Phase 3 | Completed | Sanofi | 233 | 2013-12-16 | 2018-07-27 |
| Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients Percutaneous Neurostimulation (PENS) of dermatome T7, 1200 Kcal diet - Diabetes Mellitus Type 2 in Obese, Type 2 Diabetes Mellitus With Features of Insulin Resistance | Phase 3 | Completed | Hospital General Universitario Elche | 60 | 2013-01-01 | 2014-04-25 |
| A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone Ranolazine, Placebo to match ranolazine, Metformin - Type 2 Diabetes Mellitus | Phase 3 | Completed | Gilead Sciences | 442 | 2012-06-01 | 2014-09-23 |
| Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus Ranolazine, Placebo, Glimepiride - Type 2 Diabetes Mellitus | Phase 3 | Completed | Gilead Sciences | 431 | 2012-01-01 | 2014-11-18 |
| Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus Ranolazine, Placebo, Diet - Type 2 Diabetes Mellitus | Phase 3 | Completed | Gilead Sciences | 465 | 2011-11-01 | 2014-10-24 |
| Low Energy Dense, Weight Maintenance, Risk of Cardiovascular Disease low energy dense, control, diet - Body Weight Decreased | Phase 3 | Completed | Isfahan University of Medical Sciences | 35 | 2011-01-01 | 2012-08-08 |
Showing 20 of 43. Sign in to see all of them.
Diabetes Mellitus, Type 2 (12) · Obesity (12) · Cardiovascular Diseases (7) · Diabetes Mellitus (5) · Heart Diseases (5) · Weight Loss (5) · Motor Activity (4) · Hypertension (3) · Insulin Resistance (3) · Breast Neoplasms (2) · Hypercholesterolemia (2) · Inflammation (2) · Vascular Diseases (2) · Anemia (1) · Atherosclerosis (1)
Gilead Sciences (3) · Hospital General Universitario Elche (3) · Population Health Research Institute (3) · Sanofi (3) · AstraZeneca (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Washington University School of Medicine (2) · 5 Santé (1) · Abdel Kadar Clinic (1) · Ben-Gurion University of the Negev (1) · Boston Medical Center (1) · Cedars-Sinai Medical Center (1) · Chiang Mai University (1) · Coordinación de Investigación en Salud, Mexico (1) · Hoffmann-La Roche (1)
United States (14) · Canada (6) · Czechia (4) · Hungary (4) · Poland (4) · Russia (4) · Australia (3) · Slovakia (3) · South Africa (3) · Spain (3) · Ukraine (3) · China (2) · France (2) · Israel (2) · Japan (2)
Dennis T Villareal, MD (2) · Hertzel Gerstein, MD (2) · Natalia McInnes, MD (2) · Patrick Yue, MD (2) · Adam G Tsai, MD, MSCE (1) · Agnes Floeel, MD (1) · Antonio Agudo, MD (1) · Beatriz Cirauqui Cirauqui, MD (1) · Bernd E Ringelstein, MD, Prof (1) · Caroline M. Apovian, MD (1) · Charles Hennekens (1) · David W Sparrow, DSc (1)
PMID 16636211, PMID 17327309, PMID 20151996, PMID 20187965, PMID 21449785, PMID 21689398, PMID 21786319, PMID 22424822, PMID 23630244, PMID 24451612, PMID 24787497, PMID 24947878, PMID 26049552, PMID 26358120, PMID 27289457, PMID 27625344, PMID 28432513, PMID 28951766, PMID 30013511, PMID 30226009, PMID 30458856, PMID 30509509, PMID 33512717, PMID 34728531, PMID 39356039, PMID 39880434, PMID 41406403
K24DK065018 (1), R01AG025501 (1), R01AG075684 (1), R01HL034767 (1), R01HL036821 (1), R01HL079483 (1), U01HL037852 (1), U01HL039870 (1)